SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein

被引:16
|
作者
Walter, Marius [1 ,6 ]
Chen, Irene P. [2 ,3 ,4 ]
Vallejo-Gracia, Albert [2 ,3 ,4 ]
Kim, Ik-Jung [1 ]
Bielska, Olga [1 ]
Lam, Victor L. [3 ]
Hayashi, Jennifer M. [2 ,3 ,4 ]
Cruz, Andrew [1 ]
Shah, Samah [1 ]
Soveg, Frank W. [2 ,3 ,4 ]
Gross, John D. [3 ,5 ]
Krogan, Nevan J. [2 ,3 ,4 ,5 ]
Jerome, Keith R. [6 ,7 ]
Schilling, Birgit [1 ]
Ott, Melanie [2 ,3 ,4 ,8 ]
Verdin, Eric [1 ]
机构
[1] Buck Inst Res Aging, Novato, CA 94945 USA
[2] Gladstone Inst, San Francisco, CA USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] QBI COVID 19 Res Grp QCRG, San Francisco, CA USA
[5] Univ Calif San Francisco, Quantitat Biosci Inst QBI, San Francisco, CA 94143 USA
[6] Fred Hutch Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA
[7] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
[8] Chan Zuckerberg Biohub, San Francisco, CA USA
关键词
FUNCTIONAL-ANALYSIS; RNA VIRUS; CORONAVIRUS; EXORIBONUCLEASE; DESUCCINYLATION; METABOLISM; PROMOTES; EXCISION;
D O I
10.1371/journal.ppat.1010811
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
SARS-CoV-2 non structural protein Nsp14 is a highly conserved enzyme necessary for viral replication. Nsp14 forms a stable complex with non-structural protein Nsp10 and exhibits exoribonuclease and N7-methyltransferase activities. Protein-interactome studies identified human sirtuin 5 (SIRT5) as a putative binding partner of Nsp14. SIRT5 is an NAD-dependent protein deacylase critical for cellular metabolism that removes succinyl and malonyl groups from lysine residues. Here we investigated the nature of this interaction and the role of SIRT5 during SARS-CoV-2 infection. We showed that SIRT5 interacts with Nsp14, but not with Nspl 0, suggesting that SIRT5 and Nsp10 are parts of separate complexes. We found that SIRT5 catalytic domain is necessary for the interaction with Nsp14, but that Nsp14 does not appear to be directly deacylated by SIRT5. Furthermore, knock-out of SIRT5 or treatment with specific SIRT5 inhibitors reduced SARS-CoV-2 viral levels in cellculture experiments. SIRT5 knock-out cells expressed higher basal levels of innate immunity markers and mounted a stronger antiviral response, independently of the Mitochondrial Antiviral Signaling Protein MAVS. Our results indicate that SIRT5 is a proviral factor necessary for efficient viral replication, which opens novel avenues for therapeutic interventions.
引用
收藏
页数:30
相关论文
共 50 条
  • [41] SARS-CoV-2 NSP14 induces AP-1 transcriptional activity via its interaction with MEK
    Li, Weiling
    Wang, Yuansong
    Peng, Qian
    Shi, Yingying
    Wan, Pin
    Yao, Yulin
    Bai, Tao
    Ma, Yanling
    Shu, Xiji
    Liu, Yuchen
    Sun, Binlian
    MOLECULAR IMMUNOLOGY, 2024, 175 : 1 - 9
  • [42] In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors
    Gurung, Arun Bahadur
    GENE REPORTS, 2020, 21
  • [43] Molecular interactions of Nsp14 of SARS-CoV2 with the human enzyme IMPDH2
    Testori, F.
    Genta, M.
    Ferraris, D. M.
    FEBS OPEN BIO, 2024, 14 : 488 - 489
  • [44] Potent Inhibition of SARS-CoV-2 nsp14 N7-Methyltransferase bySulfonamide-Based Bisubstrate Analogues
    Ahmed-Belkacem, Rostom
    Hausdorff, Marcel
    Delpal, Adrien
    Sutto-Ortiz, Priscila
    Colmant, Agathe M. G.
    Touret, Franck
    Ogando, Natacha S.
    Snijder, Eric J.
    Canard, Bruno
    Coutard, Bruno
    Vasseur, Jean-Jacques
    Decroly, Etienne
    Debart, Francoise
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (08) : 6231 - 6249
  • [45] Nsp14 of SARS-CoV-2 inhibits mRNA processing and nuclear export by targeting the nuclear cap-binding complex
    Katahira, Jun
    Ohmae, Tatsuya
    Yasugi, Mayo
    Sasaki, Ryosuke
    Itoh, Yumi
    Kohda, Tomoko
    Hieda, Miki
    Hirai, Masami Yokota
    Okamoto, Toru
    Miyamoto, Yoichi
    NUCLEIC ACIDS RESEARCH, 2023, 51 (14) : 7602 - 7618
  • [46] SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1
    Shilei Zhang
    Jingfeng Wang
    Lulan Wang
    Saba Aliyari
    Genhong Cheng
    Cellular & Molecular Immunology, 2022, 19 : 872 - 882
  • [47] SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1
    Zhang, Shilei
    Wang, Jingfeng
    Wang, Lulan
    Aliyari, Saba
    Cheng, Genhong
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (08) : 872 - 882
  • [48] Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2
    Martin, William R.
    Cheng, Feixiong
    JOURNAL OF PROTEOME RESEARCH, 2020, 19 (11) : 4670 - 4677
  • [49] Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs
    Narayanan, Naveen
    Nair, Deepak T.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 168 : 272 - 278
  • [50] Antiviral Potential of Antillogorgia americana and elisabethae Natural Products against nsp16-nsp10 Complex, nsp13, and nsp14 Proteins of SARS-CoV-2: An In Silico Investigation
    Pokharkar, Omkar
    Lakshmanan, Hariharan
    Zyryanov, Grigory V.
    Tsurkan, Mikhail V.
    MICROBIOLOGY RESEARCH, 2023, 14 (03) : 993 - 1019